|
US3126375A
(en)
|
|
1964-03-24 |
|
Chioacyl |
|
GB933868A
(en)
|
1958-12-08 |
1963-08-14 |
American Cyanamid Co |
Process for fluorinating steroids
|
|
IT1057859B
(it)
|
1972-04-28 |
1982-03-30 |
Sigma Tao Ind Farmaceutiche Sp |
Perivato del triamoinolone
|
|
US4588585A
(en)
|
1982-10-19 |
1986-05-13 |
Cetus Corporation |
Human recombinant cysteine depleted interferon-β muteins
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
DE3588239T3
(de)
|
1985-03-30 |
2007-03-08 |
Kauffman, Stuart A., Santa Fe |
Verfahren zum Erhalten von DNS, RNS, Peptiden, Polypeptiden oder Proteinen durch DMS-Rekombinant-Verfahren
|
|
US5618920A
(en)
|
1985-11-01 |
1997-04-08 |
Xoma Corporation |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
|
DE3600905A1
(de)
|
1986-01-15 |
1987-07-16 |
Ant Nachrichtentech |
Verfahren zum dekodieren von binaersignalen sowie viterbi-dekoder und anwendungen
|
|
US5681718A
(en)
|
1986-03-14 |
1997-10-28 |
Celltech Limited |
Methods for enhanced production of tissue plasminogen activator in cell culture using alkanoic acids or salts thereof
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US5763192A
(en)
|
1986-11-20 |
1998-06-09 |
Ixsys, Incorporated |
Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
|
|
DE3889853D1
(de)
|
1987-11-05 |
1994-07-07 |
Hybritech Inc |
Polysaccharidmodifizierte Immunglobuline mit reduziertem immunogenem Potential oder verbesserter Pharmakokinetik.
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US5010176A
(en)
|
1988-11-10 |
1991-04-23 |
Eli Lilly And Company |
Antibody-drug conjugates
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
CA2016841C
(en)
|
1989-05-16 |
1999-09-21 |
William D. Huse |
A method for producing polymers having a preselected activity
|
|
CA2016842A1
(en)
|
1989-05-16 |
1990-11-16 |
Richard A. Lerner |
Method for tapping the immunological repertoire
|
|
FI915411A0
(fi)
|
1989-05-16 |
1991-11-15 |
Scripps Research Inst |
Samexpression av heteromeriska receptorer.
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US6172197B1
(en)
|
1991-07-10 |
2001-01-09 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
ES2108048T3
(es)
|
1990-08-29 |
1997-12-16 |
Genpharm Int |
Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos.
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
DE69129154T2
(de)
|
1990-12-03 |
1998-08-20 |
Genentech, Inc., South San Francisco, Calif. |
Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
|
|
GB9109645D0
(en)
|
1991-05-03 |
1991-06-26 |
Celltech Ltd |
Recombinant antibodies
|
|
US6284471B1
(en)
|
1991-03-18 |
2001-09-04 |
New York University Medical Center |
Anti-TNFa antibodies and assays employing anti-TNFa antibodies
|
|
US7192584B2
(en)
|
1991-03-18 |
2007-03-20 |
Centocor, Inc. |
Methods of treating psoriasis with anti-TNF antibodies
|
|
US5656272A
(en)
|
1991-03-18 |
1997-08-12 |
New York University Medical Center |
Methods of treating TNF-α-mediated Crohn's disease using chimeric anti-TNF antibodies
|
|
ATE463573T1
(de)
|
1991-12-02 |
2010-04-15 |
Medimmune Ltd |
Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken
|
|
EP1291360A1
(en)
|
1991-12-13 |
2003-03-12 |
Xoma Corporation |
Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
|
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
|
CN1062869C
(zh)
|
1993-04-02 |
2001-03-07 |
比克·古尔顿·劳姆贝尔格化学公司 |
新型脱氢皮质醇衍生物
|
|
WO1994025478A1
(en)
|
1993-04-29 |
1994-11-10 |
Instytut Farmaceutyczny |
16α,17α-ACETAL GLUCOCORTICOSTEROIDAL DERIVATIVES
|
|
WO1995024416A1
(de)
|
1994-03-09 |
1995-09-14 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Neue silylverbindungen und ihre verwendung
|
|
JP2749778B2
(ja)
|
1994-09-05 |
1998-05-13 |
日清食品株式会社 |
トリアムシノロン誘導体
|
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
WO1997008320A1
(en)
|
1995-08-18 |
1997-03-06 |
Morphosys Gesellschaft Für Proteinoptimierung Mbh |
Protein/(poly)peptide libraries
|
|
US6828422B1
(en)
|
1995-08-18 |
2004-12-07 |
Morphosys Ag |
Protein/(poly)peptide libraries
|
|
US6090382A
(en)
|
1996-02-09 |
2000-07-18 |
Basf Aktiengesellschaft |
Human antibodies that bind human TNFα
|
|
US5792758A
(en)
|
1995-12-08 |
1998-08-11 |
G. D. Searle & Co. |
Steroid nitrite ester derivatives useful as anti-inflammatory drugs
|
|
DE122004000004I1
(de)
|
1996-02-09 |
2004-08-12 |
Abott Biotechnology Ltd |
Humane Antikörper welche an Humanen TNFalpha binden.
|
|
US5714352A
(en)
|
1996-03-20 |
1998-02-03 |
Xenotech Incorporated |
Directed switch-mediated DNA recombination
|
|
US5824669A
(en)
|
1996-03-22 |
1998-10-20 |
Nitromed, Inc. |
Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
|
|
DE19635498A1
(de)
|
1996-09-03 |
1998-03-26 |
Byk Gulden Lomberg Chem Fab |
Verfahren zur Epimerenanreicherung
|
|
WO2000049993A2
(en)
|
1999-02-24 |
2000-08-31 |
Nitromed, Inc. |
Nitrosated and nitrosylated steroids for the treatment of cardiovascular diseases and disorders
|
|
US8383081B2
(en)
|
1999-05-10 |
2013-02-26 |
Immunomedics, Inc. |
Anti-CD74 immunoconjugates and methods of use
|
|
WO2001002588A2
(en)
|
1999-07-02 |
2001-01-11 |
Morphosys Ag |
Generation of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests
|
|
GB0013810D0
(en)
*
|
2000-06-06 |
2000-07-26 |
Celltech Chiroscience Ltd |
Biological products
|
|
EA006231B1
(ru)
|
2000-11-10 |
2005-10-27 |
Алтана Фарма Аг |
Способ получения 16,17-[(циклогексилметилен)бис(окси)]-11,21-дигидроксипрегна-1,4-диен-3,20-диона или его 21-изобутирата транскетализацией
|
|
DE10055820C1
(de)
|
2000-11-10 |
2002-07-25 |
Byk Gulden Lomberg Chem Fab |
Verfahren zur Herstellung eines Glucocorticoids
|
|
CA2385745C
(en)
|
2001-06-08 |
2015-02-17 |
Abbott Laboratories (Bermuda) Ltd. |
Methods of administering anti-tnf.alpha. antibodies
|
|
US7595378B2
(en)
|
2001-06-13 |
2009-09-29 |
Genmab A/S |
Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
|
|
US20060073141A1
(en)
|
2001-06-28 |
2006-04-06 |
Domantis Limited |
Compositions and methods for treating inflammatory disorders
|
|
IL166244A0
(en)
|
2001-07-12 |
2006-01-15 |
Jefferson Foote |
Super humanized antibodies
|
|
US7091186B2
(en)
|
2001-09-24 |
2006-08-15 |
Seattle Genetics, Inc. |
p-Amidobenzylethers in drug delivery agents
|
|
EP2305312B1
(en)
|
2001-10-10 |
2015-03-04 |
ratiopharm GmbH |
Remodelling and glycoconjugation of follicle-stimulating hormone (FSH)
|
|
MXPA04004417A
(es)
|
2001-11-12 |
2004-08-11 |
Merck Patent Gmbh |
Anticuerpo anti-tnf alfa modificado.
|
|
US7538195B2
(en)
|
2002-06-14 |
2009-05-26 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
|
GB0216648D0
(en)
|
2002-07-18 |
2002-08-28 |
Lonza Biologics Plc |
Method of expressing recombinant protein in CHO cells
|
|
US20040157810A1
(en)
|
2002-08-23 |
2004-08-12 |
Teicher Martin H. |
Corticosteroid conjugates and uses thereof
|
|
US8232304B2
(en)
|
2002-10-24 |
2012-07-31 |
G & R Pharmaceuticals, Llc |
Antifungal formulations
|
|
MY150740A
(en)
|
2002-10-24 |
2014-02-28 |
Abbvie Biotechnology Ltd |
Low dose methods for treating disorders in which tnf? activity is detrimental
|
|
DK1578446T3
(en)
|
2002-11-07 |
2015-06-29 |
Immunogen Inc |
ANTI-CD33 ANTIBODIES AND PROCEDURES FOR TREATING ACUTE MYELOID LEUKEMIA BY USING IT
|
|
AR042461A1
(es)
|
2002-12-13 |
2005-06-22 |
Neurogen Corp |
Analogos 2-sustituidos de quinazolin-4-il - amina. composiciones farmaceuticas
|
|
JP2006516636A
(ja)
|
2003-01-30 |
2006-07-06 |
メディミューン，インコーポレーテッド |
抗インテグリンαｖβ３抗体製剤及びその用途
|
|
MY143936A
(en)
|
2003-03-27 |
2011-07-29 |
Nycomed Gmbh |
Process for preparing crystalline ciclesonide with defined particle size
|
|
WO2005044759A2
(en)
|
2003-08-14 |
2005-05-19 |
Sun Pharmaceutical Industries Limited |
Acetalization process for preparation of steroid compounds
|
|
PL1670482T5
(pl)
|
2003-09-16 |
2022-10-03 |
Covis Pharma Gmbh |
Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego
|
|
WO2005028495A1
(en)
|
2003-09-24 |
2005-03-31 |
Glaxo Group Limited |
Anti-inflammatory glucocorticoids
|
|
CA2542834C
(en)
|
2003-10-21 |
2012-04-24 |
Igf Oncology, Llc |
Conjugates or co-administration of igf-1 receptor ligands with anti-cancer chemotherapeutic agents
|
|
WO2005047284A1
(en)
|
2003-11-13 |
2005-05-26 |
F. Hoffmann-La Roche Ag |
Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones
|
|
ATE360630T1
(de)
|
2003-12-19 |
2007-05-15 |
Bristol Myers Squibb Co |
Azabicyclische heterocyclen als modulatoren des cannabinoidrezeptors
|
|
WO2005063777A1
(en)
|
2003-12-23 |
2005-07-14 |
Corus Pharma |
Benzylphosphate and substituted benzylphosphate prodrugs for the treatment of pulmonary inflammation
|
|
CA2552641A1
(en)
|
2003-12-31 |
2005-07-21 |
Cydex, Inc. |
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension
|
|
GB0402797D0
(en)
|
2004-02-09 |
2004-03-10 |
Novartis Ag |
Organic compounds
|
|
JP4942643B2
(ja)
|
2004-03-02 |
2012-05-30 |
シアトル ジェネティックス， インコーポレイテッド |
部分的に付加された抗体およびそれらの結合体化方法
|
|
WO2005075514A2
(en)
|
2004-03-10 |
2005-08-18 |
Lonza Ltd. |
Method for producing antibodies
|
|
CN103172731A
(zh)
|
2004-07-15 |
2013-06-26 |
赞科股份有限公司 |
优化的Fc变体
|
|
EP1685161A1
(en)
|
2004-08-30 |
2006-08-02 |
Lonza Biologics plc |
Affinity- plus ion exchange-chromatography for purifying antibodies
|
|
HUE058817T2
(hu)
|
2004-09-03 |
2022-09-28 |
Genentech Inc |
Humanizált anti-béta7 antagonisták és alkalmazásaik
|
|
US20080027034A1
(en)
|
2004-09-10 |
2008-01-31 |
Shah Tushar P |
Ciclesonide and Syk Inhibitor Combination and Method of Use Thereof
|
|
JO3000B1
(ar)
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
|
WO2006065533A2
(en)
|
2004-11-29 |
2006-06-22 |
Seattle Genetics, Inc. |
Engineered antibodies and immunoconjugates
|
|
WO2006097458A1
(en)
|
2005-03-15 |
2006-09-21 |
Nycomed Gmbh |
Novel combination
|
|
WO2006110593A2
(en)
|
2005-04-07 |
2006-10-19 |
Macrogenics, Inc. |
Biological targets for the diagnosis, treatment and prevention of cancer
|
|
EP1712220A1
(en)
|
2005-04-15 |
2006-10-18 |
PARI GmbH Spezialisten für effektive Inhalation |
Pharmaceutical aerosol composition
|
|
WO2006135479A2
(en)
|
2005-05-10 |
2006-12-21 |
Angiotech International Ag |
Anti-scarring agents, therapeutic compositions, and use thereof
|
|
AU2006259604A1
(en)
|
2005-06-14 |
2006-12-28 |
Gilead Sciences, Inc. |
Substituted phenylphosphates as mutual prodrugs of steroids and beta -agonists for the treatment of pulmonary inflammation and bronchoconstriction
|
|
BRPI0612529A2
(pt)
|
2005-06-20 |
2010-11-23 |
Psma Dev Company Llc |
conjugados de anticorpo-medicamento de psma
|
|
WO2007054974A2
(en)
|
2005-09-28 |
2007-05-18 |
Arch Pharmalab Limited |
A green chemistry process for the preparation of pregnadiene esters
|
|
JP2009533347A
(ja)
*
|
2006-04-07 |
2009-09-17 |
ネクター セラピューティックス エイエル，コーポレイション |
抗ＴＮＦα抗体の複合体
|
|
WO2008015696A2
(en)
|
2006-05-23 |
2008-02-07 |
Cadila Healthcare Limited |
Process for preparing ciclesonide
|
|
CL2007001536A1
(es)
|
2006-05-30 |
2008-01-25 |
Genentech Inc |
Anticuerpos anti-cd22; polinucleotidos que los codifica; vector y celula huesped que los comprende; metodo de fabricacion; metodo de deteccion del anticuerpo en una muestra biologica; inmunoconjugado que comprende al anticuerpo; composicion que lo comprende y su uso para tratar trastornos proliferativos de celulas b.
|
|
WO2009003199A1
(en)
|
2007-06-28 |
2008-12-31 |
Cydex Pharmaceuticals, Inc. |
Nasal and ophthalmic delivery of aqueous corticosteroid solutions
|
|
CA2663737A1
(en)
|
2006-09-19 |
2008-03-27 |
Cipla Limited |
Processes for the preparation of ciclesonide and its crystal form
|
|
WO2008052350A1
(en)
|
2006-11-03 |
2008-05-08 |
Qlt Inc. |
Photodynamic therapy for the treatment of hidradenitis suppurativa
|
|
US7691980B2
(en)
|
2007-01-09 |
2010-04-06 |
Bio-Rad Laboratories, Inc. |
Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
|
|
NO331891B1
(no)
|
2007-03-20 |
2012-04-30 |
Clavis Pharma Asa |
Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS
|
|
UA100120C2
(en)
|
2007-04-03 |
2012-11-26 |
Анадис Фармасьютикалз, Инк. |
5,6-dihydro-1h-pyridin-2-one compounds
|
|
CN101878221B
(zh)
|
2007-11-30 |
2014-04-02 |
辉瑞有限公司 |
糖皮质激素受体激动剂
|
|
EP2235035A2
(en)
|
2007-12-21 |
2010-10-06 |
Schering Corporation |
C-21 thioethers as glucocorticoid receptor agonists
|
|
TW200944540A
(en)
|
2007-12-21 |
2009-11-01 |
Schering Corp |
C20-C21 substituted glucocorticoid receptor agonists
|
|
WO2009092014A1
(en)
|
2008-01-18 |
2009-07-23 |
Gagnon Peter S |
Enhanced purification of antibodies and antibody fragments by apatite chromatography
|
|
US20110294766A1
(en)
|
2008-02-27 |
2011-12-01 |
Astrazeneca Ab |
16 Alpha, 17 Alpha-Acetal Glucocorticosteroidal Derivatives and their Use
|
|
JP5470817B2
(ja)
|
2008-03-10 |
2014-04-16 |
日産自動車株式会社 |
電池用電極およびこれを用いた電池、並びにその製造方法
|
|
EP2262823B1
(en)
|
2008-03-13 |
2013-01-23 |
Farmabios S.p.A. |
Process for the preparation of pregnane derivatives
|
|
US20090318396A1
(en)
|
2008-06-10 |
2009-12-24 |
Gilead Sciences, Inc. |
Corticosteroid linked beta-agonist compounds for use in therapy
|
|
KR20110028450A
(ko)
|
2008-06-16 |
2011-03-18 |
이뮤노젠 아이엔씨 |
새로운 상승 효과
|
|
US8362050B2
(en)
|
2008-06-24 |
2013-01-29 |
Irm Llc |
Compounds and methods for modulating G protein-coupled receptors
|
|
WO2010054158A2
(en)
|
2008-11-07 |
2010-05-14 |
Auspex Pharmaceuticals, Inc. |
Steroid modulators of glucocorticoid receptor
|
|
JP2012510821A
(ja)
|
2008-12-04 |
2012-05-17 |
アボット・ラボラトリーズ |
二重可変ドメイン免疫グロブリンおよびその使用
|
|
SG172254A1
(en)
|
2008-12-19 |
2011-07-28 |
Macrogenics Inc |
Covalent diabodies and uses thereof
|
|
WO2010075249A2
(en)
|
2008-12-22 |
2010-07-01 |
Genentech, Inc. |
A method for treating rheumatoid arthritis with b-cell antagonists
|
|
EP2407476B1
(en)
|
2009-03-09 |
2014-05-07 |
Mikasa Seiyaku Co,. Ltd. |
Steroid compound
|
|
WO2010126953A1
(en)
|
2009-04-29 |
2010-11-04 |
Gilead Sciences, Inc. |
Corticosteroid linked beta-agonist compounds for use in therapy
|
|
WO2010132743A1
(en)
|
2009-05-15 |
2010-11-18 |
Gilead Sciences, Inc. |
Corticosteroid beta-agonist compounds for use in therapy
|
|
SG175738A1
(en)
|
2009-05-29 |
2011-12-29 |
Pfizer Ltd |
Novel glucocorticoid receptor agonists
|
|
GB0917044D0
(en)
|
2009-09-29 |
2009-11-18 |
Cytoguide As |
Agents, uses and methods
|
|
MX2012006406A
(es)
|
2009-12-04 |
2012-07-25 |
Genentech Inc |
Anticuerpos multiespecificos, analogos de anticuerpo, composiciones y metodos.
|
|
CA2782398C
(en)
|
2009-12-09 |
2017-09-26 |
Immunomedics, Inc. |
Delivery system for cytotoxic drugs by bispecific antibody pretargeting
|
|
WO2011081937A1
(en)
|
2009-12-15 |
2011-07-07 |
Gilead Sciences, Inc. |
Corticosteroid-beta-agonist-muscarinic antagonist compounds for use in therapy
|
|
CN102167741B
(zh)
|
2010-02-25 |
2014-05-14 |
上海百迈博制药有限公司 |
一种全人源抗TNF-α单克隆抗体、其制备方法及用途
|
|
CN102958537B
(zh)
|
2010-04-07 |
2015-09-16 |
Abbvie公司 |
TNF-α结合蛋白
|
|
US9637557B2
(en)
|
2010-04-23 |
2017-05-02 |
Genentech, Inc. |
Production of heteromultimeric proteins
|
|
CA2799202C
(en)
|
2010-05-18 |
2016-07-05 |
Cerulean Pharma Inc. |
Compositions and methods for treatment of autoimmune and other diseases
|
|
HUE039740T2
(hu)
|
2010-06-03 |
2019-01-28 |
Abbvie Biotechnology Ltd |
Alkalmazások és készítmények hidradenitis suppurativa (HS) kezelésére
|
|
JP2013539353A
(ja)
|
2010-06-24 |
2013-10-24 |
アボット・ラボラトリーズ |
二重可変ドメイン免疫グロブリンおよびその使用
|
|
EP2618818A4
(en)
|
2010-09-22 |
2014-10-29 |
Map Pharmaceuticals Inc |
CORTICOSTEROID PARTICLES AND METHOD FOR PRODUCING THE SAME
|
|
AR084210A1
(es)
|
2010-12-08 |
2013-05-02 |
Abbott Lab |
PROTEINAS DE UNION AL TNF-a
|
|
WO2012082947A1
(en)
|
2010-12-16 |
2012-06-21 |
Irm Llc |
Compounds and compositions as tgr5 agonists
|
|
WO2012089247A1
(en)
|
2010-12-29 |
2012-07-05 |
Nokia Siemens Networks Oy |
A method and apparatus for transmitting an identity
|
|
CN106039306A
(zh)
|
2011-03-30 |
2016-10-26 |
埃博灵克斯股份有限公司 |
使用针对TNFα的单结构域抗体治疗免疫病症的方法
|
|
JP5827511B2
(ja)
|
2011-07-25 |
2015-12-02 |
新日鉄住金エンジニアリング株式会社 |
石炭ガスの製造方法およびメタンの製造方法
|
|
HK1200464A1
(en)
|
2011-10-24 |
2015-08-07 |
Abbvie Inc. |
Immunobinders directed against tnf
|
|
MX2014004980A
(es)
|
2011-10-24 |
2014-09-11 |
Abbvie Inc |
Inmunoaglutinantes biespecificos dirigidos contra tnf e il-17.
|
|
US20130115269A1
(en)
|
2011-11-04 |
2013-05-09 |
Henry John Smith |
Anti-tumor necrosis factor alpha (TNF-a) antibody used as a targeting agent to treat arthritis and other diseases
|
|
US20140359902A1
(en)
|
2011-12-16 |
2014-12-04 |
Synthon Biopharmaceuticals B.V. |
EXPRESSION OF SECRETORY IgA ANTIBODIES IN DUCKWEED
|
|
US9109005B2
(en)
|
2012-02-23 |
2015-08-18 |
Boehringer Ingelheim International Gmbh |
Method for manufacturing of ciclesonide
|
|
EP2641900A1
(en)
|
2012-03-20 |
2013-09-25 |
Almirall, S.A. |
Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
|
|
CN103421075B
(zh)
|
2012-05-16 |
2017-07-28 |
上海特化医药科技有限公司 |
孕烷衍生物16,17‑缩醛(酮)的制备方法
|
|
US20150158943A1
(en)
|
2012-06-01 |
2015-06-11 |
Momenta Pharmaceuticals, Inc. |
Methods related to adalimumab
|
|
US10066019B2
(en)
|
2012-10-12 |
2018-09-04 |
Agency For Science, Technology And Research |
Optimised heavy chain and light chain signal peptides for the production of recombinant antibody therapeutics
|
|
CA2891280C
(en)
|
2012-11-24 |
2018-03-20 |
Hangzhou Dac Biotech Co., Ltd. |
Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
|
|
ES2819573T3
(es)
|
2012-12-13 |
2021-04-16 |
Immunomedics Inc |
Método para producir inmunoconjugados de anticuerpo-SN-38 con un enlazador CL2A
|
|
EP2934544B1
(en)
|
2012-12-21 |
2018-11-07 |
Boehringer Ingelheim Vetmedica GmbH |
Pharmaceutical formulation comprising ciclesonide
|
|
JP6136279B2
(ja)
|
2013-01-15 |
2017-05-31 |
株式会社ジェイテクト |
転がり軸受装置
|
|
JP2016516041A
(ja)
|
2013-03-15 |
2016-06-02 |
アッヴィ・インコーポレイテッド |
改善されたｔｎｆ結合タンパク質
|
|
TWI503850B
(zh)
|
2013-03-22 |
2015-10-11 |
Polytronics Technology Corp |
過電流保護元件
|
|
US9874314B2
(en)
*
|
2013-03-27 |
2018-01-23 |
Oledworks Gmbh |
Retrofit organic light emitting diode (OLED) light source
|
|
EP3049443A4
(en)
|
2013-09-27 |
2017-04-05 |
Immunomedics, Inc. |
Anti-trop-2 antibody-drug conjugates and uses thereof
|
|
TWI510996B
(zh)
|
2013-10-03 |
2015-12-01 |
Acer Inc |
控制觸控面板的方法以及使用該方法的可攜式電腦
|
|
US20150139988A1
(en)
|
2013-11-15 |
2015-05-21 |
Abbvie, Inc. |
Glycoengineered binding protein compositions
|
|
CN106414465B
(zh)
|
2014-02-28 |
2021-11-16 |
杭州多禧生物科技有限公司 |
带电荷链接体及其在共轭反应上的应用
|
|
WO2015153401A1
(en)
*
|
2014-04-04 |
2015-10-08 |
Merck Sharp & Dohme Corp |
Phosphate based linkers for intracellular delivery of drug conjugates
|
|
CA2948013A1
(en)
|
2014-06-30 |
2016-01-07 |
Immunomedics, Inc. |
Antibodies reactive with an epitope located in the n-terminal region of muc5ac comprising cysteine-rich subdomain 2 (cys2)
|
|
EP3193829B1
(en)
|
2014-09-19 |
2021-12-08 |
Oxular Limited |
Ophthalmic drug compositions
|
|
EP3250211B1
(en)
|
2015-01-30 |
2021-12-22 |
Coral Drugs Pvt. Ltd. |
Novel process for preparation of glucocorticoid steroids
|
|
JP2016190798A
(ja)
|
2015-03-31 |
2016-11-10 |
三笠製薬株式会社 |
アレルギー性鼻炎治療用局所点鼻薬
|
|
JP2017066075A
(ja)
|
2015-09-30 |
2017-04-06 |
三笠製薬株式会社 |
リウマチ治療薬
|
|
SG10202001787QA
(en)
*
|
2016-06-02 |
2020-04-29 |
Abbvie Inc |
Glucocorticoid receptor agonist and immunoconjugates thereof
|
|
US9816280B1
(en)
|
2016-11-02 |
2017-11-14 |
Matthew Reitnauer |
Portable floor
|
|
KR20190074310A
(ko)
|
2016-11-08 |
2019-06-27 |
리제너론 파마슈티칼스 인코포레이티드 |
스테로이드 및 이의 단백질-접합체
|